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Persistent train-of-four fade in myasthenia
gravis patients after sevoflurane anaesthesia
Editor—We read with great interest the article by Nitahara
and colleagues1 showing concentration-dependent inhibi-
tory effects of sevoflurane on neuromuscular transmission
in myasthenia gravis (MG) patients which was more prom-
inent in patients with a pre-anaesthetic T4/T1,0.9. In
their study, T4/T1 returned to baseline value in all patients
at the end of anaesthesia. The importance of monitoring
pre-anaesthetic T4/T1 ratio in MG patients has been pre-
viously mentioned in a study showing significantly lower
atracurium requirements in patients with pre-anaesthetic
T4/T1,0.9.2 We also investigated T4/T1 ratio as a predic-
tor for early extubation in 11 MG patients using sevoflur-
ane and remifentanil without concomitant use of
neuromuscular blocking agents. Interestingly, five patients,
of whom only one patient showed pre-anaesthetic T4/
T1,0.9, had persistent T4/T1,0.9 at the end of anaesthe-
sia, even when the end-tidal sevoflurane concentration was
below 0.3%. Of the five patients, two had pre-anaesthetic
T4/T1.0.9, had T4/T1,0.8 and did not meet the extuba-
tion criteria (inspiratory force .25 cm H2O and vital
capacity of at least 10 ml kg21), and could not be extu-
bated in the operating room. These two patients had
similar characteristics as the other nine patients, including
serum anti-acetylcholine receptor antibody titre, except
that they had bulbar symptoms and a more severe grade of
MG.3 Sevoflurane may be a suitable anaesthetic agent for
MG patients owing to the concentration-dependent inhibi-
tory action on neuromuscular transmission with rapid
reversibility after discontinuation.1 2 However, as we
observed, persistent fade can occur at the end of sevoflur-
ane anaesthesia, regardless of the presence of pre-
anaesthetic fade, hindering early extubation even when no
neuromuscular blocking agents were used. The association
of MG severity and recovery of fade needs to be validated
in a further study and we recommend monitoring post-
recovery T4/T1 ratio as well, during sevoflurane anaesthe-
sia without the use of neuromuscular blocking agents in
MG patients to avoid unnecessary risk of respiratory com-
promise and delay in extubation.
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Editor—We appreciate the interest of Dr Kwak and col-
leagues in our article.1 In our study, the train-of-four ratios
(TOFRs) of some patients with fade or non-fade did not
return to a value 0.9. At the end of anaesthesia, although
mean TOFR returned to values not significantly different
from baseline in all three groups, TOFRs were ,0.9 in
three of 10 patients with baseline TOFR0.9 and in three
of six patients with baseline TOFR,0.9. It is unclear
whether the fade at the end of anaesthesia in MG patients
was due to the residual neuromuscular effect of sevoflur-
ane. We extubated all patients with fade since the inspira-
tory force and vital capacity met the extubation criteria. It
has been reported that during partial neuromuscular block,
although impairment of inspiratory flow and upper airway
obstruction still occurs,4 forced vital capacity and inspira-
tory force recovery to an acceptable level at TOFR.0.6.4 5
Recently, TOFR0.9 has become a standard for safe
recovery from the neuromuscular blocking drugs in
patients without neuromuscular disease. However, if we
set the extubation criteria at a TOFR above 0.9 in MG
patients, we would keep many patients intubated after
operation. In our institute, we extubate if the patient is
fully awake and inspiratory force and vital capacity meet
the criteria. Respiratory conditions are closely monitored
after extubation. To our knowledge, no standard TOFR
level has been established for safe recovery with regard to
extubation in MG patients.
Postoperative respiratory insufficiency in MG patients
may not only be caused by residual neuromuscular effect
of inhalation anaesthetics, other intraoperative factors such
as surgical invasion and the i.v. anaesthetics used, which
cannot be measured by TOFR, can also affect postopera-
tive respiratory function. In our study, anticholinesterase
and steroids were continued until the morning of surgery.
Preoperative control of MG symptoms may also influence
the postoperative respiratory conditions. It is difficult to
speculate what will be the postoperative respiratory con-
ditions simply from the preoperative TOFR from single
peripheral muscles.
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Stroke volume variation obtained with
FloTrac/VigileoTM fails to predict fluid
responsiveness in coronary artery
bypass graft patients
Editor—Recently, a new cardiac output monitoring device
(VigileoTM, Edwards Lifesciences, Irvine, CA, USA) has
been introduced in clinical practice which is based on
arterial pulse contour lacking the necessity of external
calibration.1 This device offers the possibility of a nearly
beat-to-beat measurement of cardiac output, stroke
volume, and stroke volume variation (SVV). In patients
undergoing coronary artery bypass grafting (CABG), this
system has been demonstrated to measure cardiac output
with clinically acceptable accuracy.2 However, the
reliability of SVV measured with this system in predicting
fluid responsiveness is unknown. We therefore studied 18
CABG patients monitored with a FloTrac/
VigileoTM-system (using software version 01.01) to
analyse whether this new device is suited for functional
preload monitoring.
Fourteen male and four female patients [67 (7) yr, 79
(9) kg, 174 (9) cm, mean (SD), and BSA range 1.69–
2.20 m2] undergoing CABG surgery were included in this
study. The study was approved by the institutional review
board. All patients had given written informed consent.
Stroke volume index (SVI) was measured with transpul-
monary thermodilution (PiCCOTM, Pulsion Medical
Systems, Munich, Germany) before and after a volume
load (VL) of 10 ml.kg21 hydroxyethyl starch 6% 1 h after
arrival of the patients on the intensive care unit. In
addition, central venous pressure (CVP) and SVV were
recorded. Patients were mechanically ventilated (volume
control) with a tidal volume of 8 ml.kg21 (FIO2 0.4, PEEP
5 cm H2O) maintaining normocapnia. According to the
available literature, fluid-responders were defined by an
increase in SVI12% subsequent to the VL.3 Statistical
analysis was performed using SPSS version 15.0 (SPSS
Inc, Chicago, IL, USA). Pearson’s correlation analysis was
used to describe the linear relation between preload par-
ameters before a VL and the change in SVI (DSVI)
induced by that VL. The ability to predict fluid responsive-
ness was quantified for each preload parameter by calcu-
lating the area under the receiver operating characteristic
(ROC) curve.4 A P-value of ,0.05 was considered statisti-
cally significant.
Nine patients did not respond to the fluid load. The cor-
relation coefficient for the relationship between DSVI and
CVP prior to the volume load was 0.244 (P=0.329), and
between DSVI and SVV 0.452 (P=0.069). ROC analysis
showed that both preload indicators failed to predict fluid
responsiveness. The area under the ROC curve for CVP
and for SVV were 0.685 (P¼0.185) and 0.660 (P¼0.268)
respectively.
The failure of CVP in predicting fluid responsiveness is
in accordance with increasing evidence that static preload
indicators are not suited for functional haemodynamic
monitoring.5 In contrast, a growing number of clinical
studies have clearly demonstrated the ability of dynamic
preload indicators (including SVV) to accurately predict
the response of an individual patient to a volume chal-
lenge.6 7 In contrast to these reports, we found SVV
(obtained with the FloTrac/VigileoTM system) failed to
predict fluid responsiveness. This finding might be attribu-
ted to the fact that in our system, the first software gener-
ation (version 01.01) was implemented. This version
operates with a re-calibration interval of 10 min, which is
probably too long to accurately measure changes in respir-
atory variations in the arterial pressure curve. In fact, by
employing shorter re-calibration intervals in a newer soft-
ware version, the accuracy of the FloTrac/VigileoTM
system in measuring cardiac output had been markedly
improved.8 Therefore, our findings warrant further investi-
gation whether the application of shorter re-calibration
intervals will allow using the FloTrac/VigileoTM system
for functional haemodynamic monitoring.
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